Cost-benefit analysis of ALK diagnosis vs. non-diagnosis in patients with advanced non–small cell lung cancer in Spain
A Social Return on Investment Analysis of Improving the Management of Chronic Obstructive Pulmonary Disease Within the Spanish National Healthcare System
Análisis de las estrategias dirigidas a aumentar la cobertura de vacunación antigripal en personas de 65 años y más
Análisis de las mejores estrategias para el fomento de las coberturas de vacunación antigripal entre los profesionales sanitarios
Vacunación antigripal en España en tiempos de la COVID-19: resultados de un estudio en farmacia comunitaria
Improving rheumatoid arthritis management within the Spanish National Health System: a social return on investment study
Hiperpotasemia crónica: Impacto asistencial y económico en España
The impact of improving haemophilia A management within the Spanish National Healthcare System: a social return on investment analysis
Strategic reflection on funding and access to rare disease therapies in Spain
Olaparib as first line in BRCA-mutated advanced ovarian carcinoma: Is it cost-effective in Spain?
